⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SDGR News
Schrodinger, Inc. Common Stock
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
SDGR
Form 8-K
sec.gov
SDGR
Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress
globenewswire.com
SDGR
Form 8-K
sec.gov
SDGR
Schrödinger Reports First Quarter 2026 Financial Results
businesswire.com
SDGR
AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, Chemaxon - Global Forecast to 2030 and 2035
globenewswire.com
CERT
SDGR
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
SDGR
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
SDGR
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
SDGR
Form 8-K
sec.gov
SDGR